Rivaroxaban-Mepha Teva 10mg
Rivaroxaban-Mepha Teva 10mg is a medicine authorised by Swissmedic under authorisation number 68439. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 15 March 2022 and the authorisation is valid without a time limit. ATC code B01AF01 places the medicine in the group Antithrombotic agents.
| Authorisation number | 68439 |
|---|---|
| Name | Rivaroxaban-Mepha Teva 10mg |
| Full name | Rivaroxaban-Mepha Teva 10mg, Filmtabletten |
| Authorisation holder | Mepha Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | B01AF01 |
| First authorisation | 15 March 2022 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Rivaroxaban-Mepha Teva 10mg, Filmtabletten | B | 15 March 2022 |
| 2 | Rivaroxaban-Mepha Teva 15mg, Filmtabletten | B | 15 March 2022 |
| 3 | Rivaroxaban-Mepha Teva 20mg, Filmtabletten | B | 15 March 2022 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 13 | 14 | Tablette(n) | B01AF01 | 06.03.0. | B |
| 14 | 28 | Tablette(n) | B01AF01 | 06.03.0. | B |
| 15 | 98 | Tablette(n) | B01AF01 | 06.03.0. | B |
| 16 | 100 | Tablette(n) | B01AF01 | 06.03.0. | B |
| 17 | 14 | Tablette(n) | B01AF01 | 06.03.0. | B |
| 18 | 28 | Tablette(n) | B01AF01 | 06.03.0. | B |
| 19 | 98 | Tablette(n) | B01AF01 | 06.03.0. | B |
| 20 | 100 | Tablette(n) | B01AF01 | 06.03.0. | B |
| 21 | 14 | Tablette(n) | B01AF01 | 06.03.0. | B |
| 22 | 28 | Tablette(n) | B01AF01 | 06.03.0. | B |
| 23 | 98 | Tablette(n) | B01AF01 | 06.03.0. | B |
| 24 | 100 | Tablette(n) | B01AF01 | 06.03.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Rivaroxaban-Mepha Teva 10mg authorised in Switzerland?
Yes. Rivaroxaban-Mepha Teva 10mg is authorised by Swissmedic under authorisation number 68439, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Rivaroxaban-Mepha Teva 10mg have?
Rivaroxaban-Mepha Teva 10mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Rivaroxaban-Mepha Teva 10mg?
The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.